» Authors » Peter V Danenberg

Peter V Danenberg

Explore the profile of Peter V Danenberg including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 81
Citations 2029
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Mori R, Dorff T, Xiong S, Tarabolous C, Ye W, Groshen S, et al.
Prostate . 2010 Jun; 70(15):1692-700. PMID: 20564320
Background: Androgens stimulate the expression of vascular endothelial growth factor (VEGF) through activation of hypoxia inducible factor (HIF). These genes play a major role in cancer angiogenesis. This study assesses...
12.
Grimminger P, Schneider P, Metzger R, Vallbohmer D, Danenberg K, Danenberg P, et al.
Clin Lung Cancer . 2010 Mar; 11(2):114-9. PMID: 20199977
Background: The effect of ornithine decarboxylase (ODC) on the pathogenesis of non-small-cell lung cancer (NSCLC) remains poorly investigated. Hence, the aim of this study was to explore the potential role...
13.
Grimminger P, Schneider P, Metzger R, Vallbohmer D, Danenberg K, Danenberg P, et al.
Lung Cancer . 2010 Jan; 70(1):82-7. PMID: 20064672
Background: The effect of the apoptosis related gene Bcl-2 in the pathogenesis in NSCLC remains poorly investigated. Hence the aim of this study was to explore the potential role of...
14.
Grimminger P, Stohlmacher J, Vallbohmer D, Schneider P, Holscher A, Metzger R, et al.
J Oncol . 2009 Dec; 2009:139590. PMID: 20016751
Background. To further improve the screening, diagnosis, and therapy of patients with nonsmall cell lung cancer (NSCLC) additional diagnostic tools are urgently needed. Gene expression of Cyclooxygenase-2 (COX-2) has been...
15.
Kuramochi H, Hayashi K, Nakajima G, Kamikozuru H, Yamamoto M, Danenberg K, et al.
Cancer Chemother Pharmacol . 2009 Aug; 65(5):825-31. PMID: 19701635
Purpose: High expression levels of EGFR mRNA are reported to be associated with a higher response probability in epidermal growth factor receptor (EGFR) targeted drugs. Our aim was to determine...
16.
Hoffmann A, Hoffman A, Danenberg K, Taubert H, Danenberg P, Wuerl P
Clin Cancer Res . 2009 Aug; 15(16):5191-8. PMID: 19671876
Purpose: Finding markers or gene sets that would further classify patients into different risk categories and thus allow more individually adapted multimodality treatment regimens in soft tissue sarcomas is necessary....
17.
Kuramochi H, Uchida K, Peters J, Shimizu D, Vallbohmer D, Schneider S, et al.
BMC Cancer . 2009 May; 9:157. PMID: 19460136
Background: Thymidylate synthase (TS) is known to have a unique 28 bp tandemly repeated sequence in the promoter region, and the majorities of subjects have a heterozygous double repeat/triple repeat...
18.
Kobayashi H, Sugihara K, Uetake H, Higuchi T, Yasuno M, Enomoto M, et al.
Int J Oncol . 2009 Mar; 34(4):1147-53. PMID: 19287974
Several new drugs that are targeted towards various angiogenic factors have shown considerable potential for controlling tumor proliferation and metastases. Expression levels of the targeted genes in primary tumors and...
19.
Uchida K, Danenberg P, Danenberg K, Grem J
BMC Cancer . 2008 Dec; 8:386. PMID: 19105824
Background: Over-expression of thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) in tumor tissue is associated with insensitivity to 5-fluorouracil (5-FU). Over-expression of ERCC1 correlates with insensitivity to oxaliplatin (OX) therapy,...
20.
Ohta S, Uemura H, Matsui Y, Ishiguro H, Fujinami K, Kondo K, et al.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod . 2008 Dec; 107(1):81-91. PMID: 19101490
The p16 gene encodes a 16-kDa cyclin kinase inhibitor, and the p14ARF gene a 14-kDa protein, which acts as a cell cycle regulator or tumor suppressor in human cancer cells....